In human NSCLC, the IFNγ‐iCAF is associated with IFNγ response and cytokine signalling pathways and high expression of chemokines (CCL19, CCL5), as well as MHC II [15]. The gene discussed is IFNG; the disease is non-small cell lung carcinoma.